Quidel to Acquire Assets of Alere for $440 Million

Quidel Corp, California-based leading diagnostic healthcare manufacturer, plans to purchase $440 million worth of assets from the East Coast diagnostic company, Alere Inc.

The contract specifies that Quidel would obtain Alere’s “Triage B-type naturistic peptide assay business, and its Triage MeterPro cardiovascular and technology assets for $400 million plus $40 million in contingent consideration.” This deal also includes Triage’s facility and any related real estate assets in San Diego.